Background: Enamel matrix derivative (EMD) has an extensive documentation of use in the treatment of periodontal defects. Digital volume tomography (DVT) has been in use in dental medicine since the late 1990s, with a major advantage of decreased radiation and cost-effectiveness compared to conventional computed tomography (CT). To the best of our knowledge, there is no peer-reviewed report documenting long-term tomographic assessment of an intrabony defect treated with EMD alone.

Methods: In this case report, we document the long-term response of an isolated intrabony defect treated with flap surgery plus EMD and monitored for 30 months with a DVT scan. We also compare clinical and radiographic findings for the defect at 7 and 30 months postoperatively.

Results: With regenerative treatment, significant improvements in probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BOP) were observed both short and long term. No recession occurred, and papillary heights were maintained throughout the monitoring period. Although intraoral radiography suggested bone fill at the defect site at 7 months, DVT confirmed that the intrabony defect was eliminated at 30 months.

Conclusions: Treatment of an intrabony defect with surgery plus EMD demonstrated excellent bone fill as assessed with conventional radiographic and tomographic examinations performed over 30 months. Larger studies are needed to further assess the use of DVT imaging as an appropriate adjunctive diagnostic tool for evaluating the responses of intrabony defects to regenerative techniques.

Download full-text PDF

Source
http://dx.doi.org/10.1902/jop.2008.070636DOI Listing

Publication Analysis

Top Keywords

intrabony defect
20
defect treated
12
tomographic assessment
8
assessment intrabony
8
enamel matrix
8
matrix derivative
8
surgery emd
8
months dvt
8
bone fill
8
defect
7

Similar Publications

Saving a hopeless tooth with a four-wall bone defect: A case report.

Clin Adv Periodontics

December 2024

Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Background: Recombinant human fibroblast growth factor-2 (rhFGF-2) has been shown to effectively promote the formation of new periodontal tissues, and its efficacy has been demonstrated in clinical settings. Moreover, the clinical and radiographic outcomes in the treatment of periodontal infrabony defects can be improved by using rhFGF-2 in combination with a bone substitute. Here, we present a case of four-wall bone defect in a tooth treated by combination regenerative therapy using rhFGF-2 and beta-tricalcium phosphate (β-TCP).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness of combining enamel matrix derivatives (EMD) with bone substitutes (BG) in treating periodontal defects compared to using bone substitutes alone.
  • Researchers analyzed data from 9 randomized controlled trials with a minimum follow-up of 6 months, focusing on intrabony and furcation defects.
  • The results showed that the EMD+BG combination led to a significant improvement in clinical attachment levels for intrabony defects over a 12-month period, but no benefits were observed for furcation defects.
View Article and Find Full Text PDF

CALCIUM PHOSPHATE GRAFTS COMBINED WITH GUIDED TISSUE REGENERATION IN THE TREATMENT OF PERIODONTAL BONY DEFECTS- A SYSTEMATIC REVIEW AND META-ANALYSIS.

J Evid Based Dent Pract

December 2024

Assistant Professor, Department of Restorative Dentistry, Maurice H. Kornberg School of Dentistry, Temple University, Philadelphia, PA.

Background: The objective of this systematic review is to assess the clinical outcomes of intrabony and furcation defects treated using a regenerative approach with calcium phosphate (CP) grafts combined plus guided tissue regeneration (GTR) membrane in comparison to open flap debridement (OFD).

Method: A review protocol was created under PRISMA checklist to find randomized clinical trials (RCTs) in English that compared CPs plus GTR with OFD in humans with intrabony and/or furcation defects. Both electronic and manual searches were conducted.

View Article and Find Full Text PDF

Latest update on the use of recombinant growth factors for periodontal regeneration: existing evidence and clinical applications.

Ther Adv Chronic Dis

November 2024

Division of Periodontology, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA 02115, USA.

Growth factors were introduced to increase predictability in periodontal regeneration and have since been widely applied in dentistry. This narrative review article highlights histological and latest findings of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and recombinant human fibroblast growth factor-2 (rhFGF-2) for periodontal regeneration. rhPDGF-BB enhances the proliferation and chemotaxis of periodontal ligament and alveolar bone cells.

View Article and Find Full Text PDF

Background and objective Periodontal therapy primarily aims to regenerate periodontal supporting tissues lost due to periodontitis. Autogenous bone grafts (ABG) are viewed as the gold standard method in bone regeneration and they have fewer drawbacks. Hence, many different bone-regenerating materials can be used including allografts, which have excellent biological qualities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!